Jason Wittes
Stock Analyst at Roth MKM
(2.42)
# 2,236
Out of 4,814 analysts
61
Total ratings
43.4%
Success rate
-0.11%
Average return
Main Sectors:
Stocks Rated by Jason Wittes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALUR Allurion Technologies | Reiterates: Buy | $16 | $2.35 | +580.85% | 2 | Mar 21, 2025 | |
| MGRM Monogram Technologies | Maintains: Buy | $4 → $5.4 | $2.64 | +104.55% | 2 | Mar 18, 2025 | |
| FBIO Fortress Biotech | Reiterates: Buy | $15 → $16 | $1.51 | +959.60% | 3 | Mar 11, 2025 | |
| OFIX Orthofix Medical | Reiterates: Buy | $22 | $13.05 | +68.58% | 5 | Feb 26, 2025 | |
| IRMD IRADIMED CORPORATION | Reiterates: Buy | $60 → $72 | $51.50 | +39.81% | 3 | Feb 14, 2025 | |
| TLSI TriSalus Life Sciences | Reiterates: Buy | $11 | $5.78 | +90.31% | 2 | Jan 24, 2025 | |
| GMED Globus Medical | Maintains: Buy | $100 → $115 | $72.35 | +58.95% | 4 | Dec 17, 2024 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $36 | $5.77 | +523.92% | 1 | Jul 24, 2024 | |
| DERM Journey Medical | Reinstates: Buy | $11 | $6.21 | +77.13% | 1 | Jun 28, 2024 | |
| CRDL Cardiol Therapeutics | Initiates: Buy | $10 | $1.00 | +900.00% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $100 | $86.28 | +15.90% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $348 → $405 | $346.60 | +16.85% | 10 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.83 | +173.22% | 4 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $1.50 | +502.01% | 2 | Feb 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $31.89 | +135.18% | 2 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $10.54 | +108.83% | 3 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $120 | $97.88 | +22.60% | 7 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $206 | $152.40 | +35.17% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $145 | $199.89 | -27.46% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $8.32 | +80.29% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $200 | $15.56 | +1,185.35% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $38.32 | -32.15% | 1 | Feb 22, 2017 |
Allurion Technologies
Mar 21, 2025
Reiterates: Buy
Price Target: $16
Current: $2.35
Upside: +580.85%
Monogram Technologies
Mar 18, 2025
Maintains: Buy
Price Target: $4 → $5.4
Current: $2.64
Upside: +104.55%
Fortress Biotech
Mar 11, 2025
Reiterates: Buy
Price Target: $15 → $16
Current: $1.51
Upside: +959.60%
Orthofix Medical
Feb 26, 2025
Reiterates: Buy
Price Target: $22
Current: $13.05
Upside: +68.58%
IRADIMED CORPORATION
Feb 14, 2025
Reiterates: Buy
Price Target: $60 → $72
Current: $51.50
Upside: +39.81%
TriSalus Life Sciences
Jan 24, 2025
Reiterates: Buy
Price Target: $11
Current: $5.78
Upside: +90.31%
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100 → $115
Current: $72.35
Upside: +58.95%
Mind Medicine (MindMed)
Jul 24, 2024
Maintains: Buy
Price Target: $36
Current: $5.77
Upside: +523.92%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $6.21
Upside: +77.13%
Cardiol Therapeutics
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $1.00
Upside: +900.00%
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $86.28
Upside: +15.90%
May 1, 2024
Maintains: Buy
Price Target: $348 → $405
Current: $346.60
Upside: +16.85%
Mar 5, 2024
Reiterates: Buy
Price Target: $5
Current: $1.83
Upside: +173.22%
Feb 13, 2024
Initiates: Buy
Price Target: $9
Current: $1.50
Upside: +502.01%
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $31.89
Upside: +135.18%
Oct 20, 2023
Initiates: Buy
Price Target: $22
Current: $10.54
Upside: +108.83%
Oct 20, 2023
Initiates: Neutral
Price Target: $120
Current: $97.88
Upside: +22.60%
Sep 14, 2022
Initiates: Buy
Price Target: $206
Current: $152.40
Upside: +35.17%
Jun 27, 2022
Reinstates: Buy
Price Target: $145
Current: $199.89
Upside: -27.46%
Mar 3, 2022
Initiates: Buy
Price Target: $15
Current: $8.32
Upside: +80.29%
Feb 8, 2022
Initiates: Buy
Price Target: $200
Current: $15.56
Upside: +1,185.35%
Feb 22, 2017
Initiates: Buy
Price Target: $26
Current: $38.32
Upside: -32.15%